1. Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma. (April 2021) Authors: Jun, Tomi; Ozbek, Umut; Dharmapuri, Sirish; Hardy-Abeloos, Camille; Zhu, Huili; Lin, Jung-Yi; Personeni, Nicola; Pressiani, Tiziana; Nishida, Naoshi; Lee, Pei-Chang; Lee, Chieh-Ju; Hildebrand, Hannah; Nimkar, Neil; Paul, Sonal; Fessas, Petros; Naeem, Muntaha; Bettinger, Dominik; Khan, Uqba; Saeed... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resection. Issue 6 (10th June 2022) Authors: Chen, Yu-Jen; Su, Chien-Wei; Wei, Cheng-Yi; Chau, Gar-Yang; Chen, Ping-Hsien; Chao, Yee; Huang, Yi-Hsiang; Wu, Jaw-Ching; Yang, Tsung-Chieh; Lee, Pei-Chang; Hou, Ming-Chih Journal: Journal of the Chinese Medical Association Issue: Volume 85:Issue 6(2022) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma. (May 2022) Authors: Huang, Kuo-Wei; Lee, Pei-Chang; Chao, Yee; Su, Chien-Wei; Lee, I-Cheng; Lan, Keng-Hsin; Chu, Chi-Jen; Hung, Yi-Ping; Chen, San-Chi; Hou, Ming-Chih; Huang, Yi-Hsiang Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early echocardiographic signs of diastolic dysfunction predict acute kidney injury in cirrhotic patients. Issue 11 (4th September 2020) Authors: Wu, Pei-Shan; Wang, Ying-Wen; Tai, Cheng-Chun; Hsieh, Yun-Cheng; Lee, Pei-Chang; Huang, Chin-Chou; Huang, Yi-Hsiang; Hou, Ming-Chih; Lin, Han-Chieh; Lee, Kuei-Chuan Journal: Journal of the Chinese Medical Association Issue: Volume 83:Issue 11(2020) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma. Issue 6 (23rd June 2022) Authors: Lee, Pei-Chang; Wu, Chi-Jung; Hung, Ya-Wen; Lee, Chieh Ju; Chi, Chen-Ta; Lee, I-Cheng; Yu-Lun, Kuo; Chou, Shih-Hsuan; Luo, Jiing-Chyuan; Hou, Ming-Chih; Huang, Yi-Hsiang Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received endoscopic retrograde cholangiopancreatography: A single-center retrospective study. Issue 2 (17th December 2022) Authors: Li, Chia-Ju; Chang, Tien-En; Hou, Ming-Chih; Huang, Yi-Hsiang; Lee, Pei-Chang; Chang, Nai-Wen; Chen, Yu-Jen; Lee, Fa-Yuah Journal: Journal of the Chinese Medical Association Issue: Volume 86:Issue 2(2023) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy. Issue 3 (March 2020) Authors: Lee, Pei-Chang; Chen, Yu-Ju; Chou, Yueh-Ching; Lee, Kuei-Chuan; Chen, Ping-Hsien; Kao, Wei-Yu; Huang, Yi-Hsiang; Huo, Teh-Ia; Lin, Han-Chieh; Hou, Ming-Chih; Lee, Fa-Yauh; Wu, Jaw-Ching; Su, Chien-Wei Journal: European journal of gastroenterology & hepatology Issue: Volume 32:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. Issue 2 (30th August 2020) Authors: Lee, Pei-Chang; Chao, Yee; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, I-Cheng; Hou, Ming-Chih; Huang, Yi-Hsiang Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. Issue 2 (30th August 2020) Authors: Lee, Pei-Chang; Chao, Yee; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, I-Cheng; Hou, Ming-Chih; Huang, Yi-Hsiang Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. Issue 2 (30th August 2020) Authors: Lee, Pei-Chang; Chao, Yee; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, I-Cheng; Hou, Ming-Chih; Huang, Yi-Hsiang Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗